{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:55:25Z","timestamp":1781571325763,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006447","name":"Universit\u00e4t Z\u00fcrich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.xkme.2025.101172","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:01:02Z","timestamp":1762315262000},"page":"101172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Osmotic Nephropathy Induced by L-Proline Stabilized Sucrose-free Intravenous Immunoglobulins: A Case Report"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2245-2978","authenticated-orcid":false,"given":"Antonio","family":"Ulpiano Trillig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Rotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mehier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Rossier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xkme.2025.101172_bib1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1053\/j.ajkd.2007.10.044","article-title":"Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes","volume":"51","author":"Dickenmann","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.xkme.2025.101172_bib2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/j.ajkd.2023.09.017","article-title":"Toxic nephropathies of the tubulointerstitium: core curriculum 2024","volume":"83","author":"Krishnan","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1016\/j.xkme.2025.101172_bib3","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2215\/CJN.00150118","article-title":"Pharmacology behind common drug nephrotoxicities","volume":"13","author":"Perazella","year":"2018","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"1","key":"10.1016\/j.xkme.2025.101172_bib4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/j.ajkd.2020.01.015","article-title":"Osmotic nephrosis and acute kidney injury associated with SGLT2 inhibitor use: a case report","volume":"76","author":"Phadke","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.xkme.2025.101172_bib5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.34067\/KID.0007882021","article-title":"Drug-induced osmotic nephropathy: add SGLT2-inhibitors to the list?","volume":"3","author":"Perazella","year":"2021","journal-title":"Kidney360"},{"issue":"4","key":"10.1016\/j.xkme.2025.101172_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000354893","article-title":"Intravenous immunoglobulins: in-depth review of excipients and acute kidney injury risk","volume":"38","author":"Dantal","year":"2013","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101172_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/j.ajkd.2009.06.013","article-title":"Hemoglobinuria and acute kidney injury requiring hemodialysis following intravenous immunoglobulin infusion","volume":"55","author":"Welles","year":"2010","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"2","key":"10.1016\/j.xkme.2025.101172_bib8","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1053\/j.ajkd.2016.12.003","article-title":"AJKD atlas of renal pathology: osmotic tubular injury","volume":"69","author":"Fogo","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.xkme.2025.101172_bib9","doi-asserted-by":"crossref","DOI":"10.1053\/j.ajkd.2016.03.003","article-title":"AJKD Atlas of renal pathology: ischemic acute tubular injury","volume":"67","author":"Fogo","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2025.101172_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-physiol-022516-034234","article-title":"Receptor-mediated endocytosis in the proximal tubule","volume":"79","author":"Eshbach","year":"2017","journal-title":"Annu Rev Physiol"},{"issue":"5","key":"10.1016\/j.xkme.2025.101172_bib11","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1681\/ASN.2015020185","article-title":"Light chain proximal tubulopathy: clinical and pathologic characteristics in the modern treatment era","volume":"27","author":"Stokes","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.xkme.2025.101172_bib12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00424-022-02701-y","article-title":"Metabolic mechanisms of acute proximal tubular injury","volume":"474","author":"Hall","year":"2022","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.xkme.2025.101172_bib13","first-page":"255","article-title":"Amino Acid Transporters of Epithelia","volume":"3","author":"Camargo","year":"2020"},{"key":"10.1016\/j.xkme.2025.101172_bib14","series-title":"Emery and Rimoin\u2019s Principles and Practice of Medical Genetics and Genomics","first-page":"49","article-title":"3 - Amino acid metabolism","author":"Sanchez Russo","year":"2021"},{"issue":"1","key":"10.1016\/j.xkme.2025.101172_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41439-021-00159-5","article-title":"Hyperprolinemia type I caused by homozygous p.T466M mutation in PRODH","volume":"8","author":"Hama","year":"2021","journal-title":"Hum Genome Var"},{"issue":"8","key":"10.1016\/j.xkme.2025.101172_bib16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/humu.21296","article-title":"Type I hyperprolinemia: genotype\/phenotype correlations","volume":"31","author":"Guilmatre","year":"2010","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.xkme.2025.101172_bib17","article-title":"[Type I hyperprolinemia - what about the kidney?]","volume":"40","author":"Rizzo","year":"2023","journal-title":"G Ital Nefrol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101172_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00424-009-0638-2","article-title":"Kidney amino acid transport","volume":"458","author":"Verrey","year":"2009","journal-title":"Pflugers Arch"},{"issue":"5","key":"10.1016\/j.xkme.2025.101172_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036616","article-title":"Proton-assisted amino acid transporter PAT1 complexes with Rag GTPases and activates TORC1 on late endosomal and lysosomal membranes","volume":"7","author":"\u00d6gmundsd\u00f3ttir","year":"2012","journal-title":"PloS One"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525002080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525002080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:35:41Z","timestamp":1781570141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059525002080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2590059525002080"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101172","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osmotic Nephropathy Induced by L-Proline Stabilized Sucrose-free Intravenous Immunoglobulins: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101172"}}